About ANGELO KAGGWA
Role(s) / Profession(s)
- Technical Specialist, Advisor
Website: http://www.avac.org/ Type: Non-Governmental Organization Country: United States About: AVAC is an international non-profit organization that uses education, policy analysis, advocacy, and community mobilization to accelerate the ethical development and eventual global delivery of AIDS vaccines and other new HIV prevention options as part of a comprehensive response to the pandemic.
- United States
ANGELO KAGGWA started a discussion "AVAC Report 2012: Achieving the End - One Year and Counting". in the [ARCHIVED] HIV Prevention community.
November 27, 2012 Dear Advocates, Today AVAC published Achieving the End: One Year and Counting, our 2012 Report on the state of biomedical HIV prevention research and implementation. The full report, executive summary and downloadable graphics and PowerPoints are available at www.avac.org/report2012. Achieving the End: One Year and Counting sets ...
ANGELO KAGGWA started a discussion "AVAC launches call for applications for 2013 Advocacy Fellowships". in the [ARCHIVED] HIV Prevention community.
May 31, 2012 Dear Advocates, AVAC is pleased to announce the call for applications for the 2013 HIV Prevention Research Advocacy Fellowship Program . This update provides information on the Advocacy Fellowship program and details for an upcoming informational call to be held on Monday, June 25. The submission deadline ...
ANGELO KAGGWA started a discussion "AVAC on HIV Vaccine Awareness Day: Key messages and new materials". in the [ARCHIVED] HIV Prevention community.
May 17, 2012 Dear Advocates, On May 18, HIV Vaccine Awareness Day (HVAD), HIV prevention advocates around the globe will raise their voices about the urgent need to continue the search for a powerful HIV prevention tool: an effective vaccine. This update contains links to several exciting new resources that ...
ANGELO KAGGWA started a discussion "FDA Committee Recommends TDF/FTC (Truvada) as PrEP: Summary and May 15 global call". in the [ARCHIVED] HIV Prevention community.
May 11, 2012 Dear Advocates, Yesterday an Advisory Committee to the US Food and Drug Administration (FDA) recommended that the antiretroviral TDF/FTC (brand name Truvada) be licensed for use as an HIV prevention tool for HIV-negative people in the US. This development moves the field one step closer to a ...
Thank you all for your feedback to my personal experience. Ashley, thank you for your kind words. Glad to know that sharing my experience has made you reflect on “practicing what you preach”. I’m humbled. After reading all the responses, I would like to emphasize and clarify a few things. ...
- None at this time.